E0 ConsensusModerate confidencePEM not requiredReview-NarrativePeer-reviewedReviewed
The management of fibromyalgia.
Rao, Srinivas G, Clauw, Daniel J · Drugs of today (Barcelona, Spain : 1998) · 2004 · DOI
Quick Summary
This guideline reviews how fibromyalgia is managed and notes that it shares similarities with other conditions like ME/CFS, irritable bowel syndrome, and chronic headaches. These conditions cause pain that comes from the central nervous system rather than from injured tissue, which means common pain medications like NSAIDs and opioids don't work well. Instead, certain antidepressants, anti-seizure drugs, exercise, and talk therapy tend to be more helpful.
Why It Matters
This guideline is relevant to ME/CFS patients because it explicitly acknowledges ME/CFS as one of several overlapping functional somatic syndromes and suggests they may share neurobiological mechanisms. The treatment recommendations—prioritizing neuroactive drugs and behavioral therapies over traditional pain medications—provide evidence-based guidance applicable to ME/CFS management. It also validates the inadequacy of peripheral pain models for understanding these conditions.
Observed Findings
- Fibromyalgia, ME/CFS, irritable bowel syndrome, chronic headache, and chronic idiopathic lower back pain show overlapping features and more commonly affect females than males.
- Pain in functional somatic syndromes is central in origin rather than peripheral, explaining poor treatment response to NSAIDs and opioids.
- Tricyclic antidepressants and antiseizure drugs show greater efficacy for central pain conditions than traditional peripheral pain medications.
- Aerobic exercise and cognitive behavioral therapy demonstrate clinical effectiveness but are underutilized in routine clinical practice.
Inferred Conclusions
- Functional somatic syndromes including ME/CFS, fibromyalgia, and related conditions likely share common underlying neurobiological mechanisms and may benefit from similar treatment approaches.
- Central sensitization models better explain the pain pathophysiology in these conditions than peripheral injury models, suggesting different pharmacological strategies are needed.
- Non-pharmacological interventions such as exercise and cognitive behavioral therapy should be more routinely implemented alongside or instead of pharmacological treatments.
Remaining Questions
- What are the specific shared neurobiological mechanisms across functional somatic syndromes, and how do they differ between individuals?
- How should aerobic exercise be tailored for ME/CFS patients given post-exertional malaise concerns, which differ from fibromyalgia exercise responses?
What This Study Does Not Prove
This guideline does not prove that fibromyalgia and ME/CFS are identical conditions or that all treatment approaches effective in one are equally effective in the other. It does not provide direct clinical trial data comparing specific medications or therapies, nor does it establish causation for the proposed shared mechanisms—only correlation. The overlap noted does not establish whether these are truly one spectrum of disease or distinct conditions with coincidental similarities.
Tags
Symptom:PainFatigue
Method Flag:PEM Not DefinedWeak Case Definition
Metadata
- DOI
- 10.1358/dot.2004.40.6.850485
- PMID
- 15349132
- Review status
- Editor reviewed
- Evidence level
- Higher-level evidence type — systematic reviews, meta-analyses, guidelines, or major syntheses (study type, not a quality guarantee)
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.